Melanoma: open trials in Netherlands

43 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT07519655
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Trial Treatment · Phase 1 · Pfizer
Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL), Amsterdam
Registry updated 2026-11-05
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-11-03
NCT06743126
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
Trial Treatment · Phase 3 · Immatics US, Inc.
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-10-30
NCT07224425
A Study of BI 3810944 in Patients With Advanced Cancer
Trial Treatment · Phase 1 · Boehringer Ingelheim
Radboud universitair medisch centrum Stichting, Nijmegen
Registry updated 2026-10-30
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Amsterdam UMC Locatie VUMC, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Leids Universitair Medisch Centrum, Leiden · Maastricht University Medical Center, Maastricht · Radboud University Medical Center, Nijmegen
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Radboud Universitair Medisch Centrum (Radboudumc), Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-26
NCT07501780
Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice
Research · Maastricht University Medical Center
Maastricht University Medical Center, Maastricht
Registry updated 2026-10-19
2026-526261-14-00
PHOENIX - ECP: Extracorporeal PHotopheresis for immune-related cOlitis and/or hEpatitis in advanced melaNoma with inadequate response to steroId eXposure
Trial Treatment · Phase 2 · Therakos Europe Limited
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam
Registry updated 2026-10-05
NCT05727904
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Trial Treatment · Phase 3 · Iovance Biotherapeutics, Inc.
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam
Registry updated 2026-09-24
NCT07338968
A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
Research · Phase 3 · Aura Biosciences
Leids Universitair Medisch Centrum (LUMC), Leiden · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-08-19
NCT05701176
A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer
Trial Treatment · Phase 1/2 · Amsterdam UMC, location VUmc
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-08-18
NCT06457789
Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer
Trial Treatment · Phase 2/3 · Amsterdam UMC, location VUmc
Amsterdam UMC, Amsterdam
Registry updated 2026-08-18
NCT07696715
Timing of Immunotherapy in Melanoma
Trial Treatment · Radboud University Medical Center
Amsterdam UMC, Amsterdam · Antoni van Leeuwenhoek, Amsterdam · Leiden UMC, Leiden · Radboudumc, Nijmegen · ErasmusMC, Rotterdam
Registry updated 2026-08-13
NCT07686835
Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.
Trial Treatment · Phase 2 · Radboud University Medical Center
Universitair Medisch Centrum Groningen, Groningen · Medical Oncology, Nijmegen
Registry updated 2026-07-27
NCT07511933
Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases
Trial Treatment · The Netherlands Cancer Institute
Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam
Registry updated 2026-07-24
2023-506400-99-00
Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL
Trial Treatment · Phase 2 · Vall D Hebron Institute Of Oncology
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam
Registry updated 2026-07-23
NCT02332668
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-07-06
NCT06246149
Adjuvant Tebentafusp in High Risk Ocular Melanoma
Trial Treatment · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC
Leids Universitair Medisch Centrum (LUMC), Leiden · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-06-30
NCT07615881
Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in Patients With Melanoma
Trial Treatment · Phase 1/2 · Amsterdam UMC, location VUmc
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-05-29
NCT07015190
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Trial Treatment · Phase 3 · IDEAYA Biosciences
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-05-06
NCT05522660
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · ETOP IBCSG Partners Foundation
NKI-AVL, Amsterdam
Registry updated 2026-04-27
NCT07530887
NO Re-excision MelanomA - NORMA 2
Trial Treatment · Phase 3 · Marieke Goodijk
Noordwest Ziekenhuisgroep, Alkmaar · Flevoziekenhuis, Almere Stad · Antoni van Leeuwenhoek, Amsterdam · Gelre Ziekenhuizen, Apeldoorn · Rijnstate Ziekenhuis, Arnhem · Catharina Ziekenhuis, Eindhoven · Medisch Spectrum Twente, Enschede · Groene Hart Ziekenhuis, Gouda · Martini Ziekenhuis, Groningen · Tergooi MC, Hilversum · Dijklander Ziekenhuis, Hoorn · Leids Universitair Medisch Centrum, Leiden · Alrijne Ziekenhuis, Leiden · Maastricht UMC, Maastricht · Maasstad Ziekenhuis, Rotterdam · Jeroen Bosch Ziekenhuis, 's-Hertogenbosch · Haaglanden Medisch Centrum, The Hague · Haga Ziekenhuis, The Hague · Diakonessenhuis, Utrecht · St Antonius Ziekenhuis, Utrecht · Isala Ziekenhuis, Zwolle
Registry updated 2026-04-15
2024-520052-19-04
Research on two creams (Monobenzon / Imiquimod) together with the standard treatment for advanced or metastatic melanoma (ImMI).
Trial Treatment · Phase 1/2 · Amsterdam UMC Stichting
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-04-13
NCT07310758
Contrast-enhanced Ultrasound for Sentinel Node Detection
Trial Treatment · Phase 2/3 · The Netherlands Cancer Institute
Netherlands Cancer Institute, Amsterdam
Registry updated 2025-12-30
NCT07206017
Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.
Trial Treatment · University Medical Center Groningen
UMCG, Groningen
Registry updated 2025-10-03

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error